Clinical Trials Browser

Interventional × Hepatitis B × 1 year × Clear all

NCT07253220 2025-11-28

TAF Monotherapy Versus ETV Combined With TAF on the Efficacy and Prognosis of Immunotherapy for Hepatitis B-Related Hepatocellular Carcinoma

Phase NA Not yet recruiting

Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular

NCT06084234 2025-11-26

TRACER

Phase 4 Recruiting

Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular, Liver Cirrhosis, Liver Neoplasms

NCT07038863 2025-06-26

Mondelta

Phase NA Not yet recruiting

Gastrointestinal

Hepatitis D, Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Liver Cirrhosis

NCT03534141 2025-05-16

MHALT

Phase NA Terminated

175 enrolled 19 charts

GastrointestinalGenitourinary

Fibrosis, Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Hypothermia, Liver Cirrhosis, Alcoholic, Renal Insufficiency, Chronic, Acute Kidney Injury, End Stage Liver Disease, Non-alcoholic Fatty Liver Disease

NCT04000737 2025-04-13

YIV-906 (Formerly PHY906/KD018) With Sorafenib in HBV(+) Hepatocellular Carcinoma (HCC)

Phase 2 Completed

Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular